查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1661279

2025 年至 2033 年人造器官市場規模、佔有率、趨勢及預測（按類型和地區）

Artificial Organs Market Size, Share, Trends and Forecast by Type and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球人工器官市場規模達到 222 億美元。北美目前佔據市場主導地位，到 2024 年的市場佔有率將超過 45.0%。

與傳統的金屬、礦物和合成材料相比，生物材料具有高導電性、強度、生物相容性和生物分解性。因此，先進生物材料在人工器官中的應用不斷增加，目前是推動市場成長的主要驅動力之一。除此之外，生物材料在醫療器材、組織工程、藥物和基因傳遞、微創手術（MIS）和生物感測器領域的應用也在增加。除此之外，由於全球範圍內器官衰竭和疾病的數量不斷增加，對人工器官中生物材料的需求也不斷成長，這對市場產生了積極影響。

報告涵蓋了市場結構、主要參與者的市場佔有率、參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。市場結構本質上是分散的，有大量國際和地區參與者參與該行業。由於產品差異化和轉換成本較低，人工器官產業的新進入者數量適中。然而，嚴格的政府政策法規和高昂的投資成本阻礙了新進業者進入人工器官市場。

什麼是人造器官？

人工器官是經過特殊設計的裝置，可以植入人體來取代原來的器官。它們是透過從移植接受者身上獲得的各種材料製造的，例如金屬、無生命聚合物、活細胞和接種幹細胞的塑膠。它們被廣泛用作腎臟、肺、肝、心臟、人工胰腺和人工耳蝸。它們非常適合人體，因為人體的免疫系統不會排斥人工器官。它們不需要持續依賴電源或任何其他固定資源來維持嚴重器官衰竭患者的生命。它們協助提供與健康器官類似的功能或執行特定的功能。他們還協助提供生命維持，以防止在等待移植期間瀕臨死亡。除此之外，它還有利於透過美容修復、癌症手術後或事故改善患者的生活。由於它們能夠挽救人們的生命並協助人們進行活動，因此全球對人工器官的需求正在上升。

COVID-19 影響：

新冠肺炎疫情爆發，為各行各業帶來嚴峻考驗，也為各國帶來前所未有的挑戰。由於人工器官是必需品，因此其產業並未受到疫情的嚴重阻礙。該行業的生產設施或單位並未關閉。不過，由於原料產業供應鏈中斷，疫情初期人工器官的生產受到了影響。同時，由於擔心病毒廣泛傳播，勞動力短缺，這在新冠疫情爆發的最初幾個月影響了人工器官市場。此外，各國管理機構對道路運輸都制定了嚴格的規章制度，阻礙了物流和運輸業的發展。這在短期內對人工器官產業的供應鏈造成了暫時影響。此外，全球移植治療和診斷率較低，迫使主要參與者降低生產能力，並在疫情期間面臨相當大的經濟損失。此外，由於世界各地對商品和服務進出口等貿易活動的跨境限制和禁令，對人造器官的需求有所下降。此外，與在體內植入人工器官相比，人們更關注與冠狀病毒相關的治療方案。然而，在重新開放封鎖措施後，預計未來幾年對人造器官的需求將會增加。

人工器官市場趨勢：

目前，由於全球器官捐贈者數量減少，對人工器官的需求增加是積極影響市場的主要因素之一。此外，由於全球範圍內器官衰竭和殘疾人數不斷增加，人工器官的採用也不斷增加，這也促進了市場的成長。除此之外，穿戴式科技、微晶片技術和非侵入性診斷技術等醫療設備的各種技術進步都為市場帶來了積極的前景。除此之外，先進生物材料在人工器官中的應用越來越多，以提供高強度、導電性和生物相容性，為產業投資者提供了豐厚的成長機會。此外，世界各地對於非常適合改善人們生活的人造器官的需求也不斷增加。再加上由於生活習慣和生活方式的改變，大眾患上生活方式相關疾病的數量不斷增加，推動了市場的成長。與此相符的是，人們越來越傾向於使用精確診斷方法來監測人工器官，這推動了市場的成長。此外，主要參與者正在將人工智慧（AI）和嵌入式感測器引入人工器官，從而增強市場的成長。

本報告解答的關鍵問題

  • 什麼是人造器官？人造器官市場有多大？
  • 2025-2033年全球人工器官市場的預期成長率是多少？
  • 推動全球人工器官市場發展的關鍵因素有哪些？
  • 根據類型，全球人工器官市場的主要細分市場是什麼？
  • 全球人工器官市場的主要區域有哪些？
  • 全球人工器官市場的關鍵參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球人工器官市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場區隔：按類型
  • 市場分佈：按地區
  • 市場預測
  • SWOT 分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
    • 概述
    • 研究與開發
    • 原物料採購
    • 製造業
    • 行銷
    • 分配
    • 最終用途
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第6章：市場細分：依類型

  • 人工腎臟
    • 市場趨勢
    • 市場預測
  • 人工心臟
    • 市場趨勢
    • 市場預測
  • 人工胰臟
    • 市場趨勢
    • 市場預測
  • 人工耳蝸
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章：市場區隔：依地區

  • 北美洲
    • 市場趨勢
    • 市場預測
  • 歐洲
    • 市場趨勢
    • 市場預測
  • 亞太地區
    • 市場趨勢
    • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 市場預測
  • 拉丁美洲
    • 市場趨勢
    • 市場預測

第 8 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abiomed, Inc.
    • HeartWare International, Inc.
    • Edwards Lifesciences Corp
    • Boston Scientific Corporation
    • Cochlear Limited
Product Code: SR112025A833

The global artificial organs market size reached USD 22.2 Billion in 2024. Looking forward, the IMARC Group expects the market to reach USD 44.5 Billion by 2033, exhibiting a growth rate CAGR of 7.22% during 2025-2033. North America currently dominates the market, holding a market share of over 45.0% in 2024. The increasing need for 3D bioprinting due to its capability to minimize the risk of organ rejection, rising prevalence of chronic diseases, such as cancer, diabetes, hypertension, stroke, heart disease, and respiratory diseases, and escalating demand for organ transplantation.

Biomaterials offer high conductivity, strength, bio-compatibility, and bio-degradability as compared to conventional metal, mineral, and synthetic-based materials. As a result, there is a rise in the adoption of advanced biomaterials in artificial organs, which currently represents one of the primary drivers contributing to the growth of the market. In addition to this, there is an increase in the utilization of biomaterials in medical devices, tissue engineering, drug and gene delivery, minimally invasive surgery (MIS), and biosensors. Apart from this, the growing demand for biomaterials in artificial organs due to the increasing number of organ failures and diseases among individuals across the globe is positively influencing the market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is fragmented in nature with a large number of international and regional players operating in the industry. The volume of new entrants is moderate in the artificial organs industry on account of the low product differentiation and switching costs. However, stringent government policies and regulations and high investment costs hinder the entry of new entrants in the artificial organ market.

What are Artificial Organs?

Artificial organs are engineered devices designed to be implanted in a human body as an alternative to the original organ. They are manufactured through various materials, such as metals, inanimate polymers, living cells, and plastic seeded with stem cells, that are obtained from the transplant recipient. They are widely available as kidney, lung, liver, heart, and artificial pancreas, and cochlear implants. They are highly suitable for the body as the immune system of the body does not reject the artificial organ. They do not require continuous tethering to a power supply or any other stationary resource to keep patients with serious organ failure. They assist in providing similar functions of a healthy organ or performing a specific function. They also aid in offering life support to prevent imminent death while waiting for a transplant. Besides this, it is beneficial in improving the life of a patient through cosmetic restoration, post-cancer surgery or an accident. As they save the life of individuals and aid in performing activities, the demand for artificial organs is rising across the globe.

COVID-19 Impact:

The COVID-19 pandemic outbreak has caused severe problems for numerous industries and imposed unprecedented challenges on various countries. The artificial organ industry was not severely hampered by the pandemic as these are essential products. The production facilities or units of the industry were not shut down. Although, the manufacturing of artificial organs has been affected in the initial period of the pandemic on account of the supply chain disruptions from the raw materials industry. In line with this, there was a shortage of labor due to the fear of the widespread virus, which impacted the artificial organs market in the starting months of the COVID-19 pandemic. Apart from this, governing agencies of various countries have imposed stringent rules and regulations on on-road movement, which hampered the logistical and transportation industry. This has temporarily impacted the supply chain in the short term for the artificial organs industry. Moreover, there was a lower rate of transplant treatment and diagnostic across the globe that forced key players to descale their production capacity, and they faced some considerable financial losses during the pandemic. Besides this, there was a declined demand for artificial organs on account of the cross-border restrictions and bans on trade activities, such as imports and exports of goods and services around the world. Additionally, people were more focused on the treatment options related to the coronavirus as compared to implanting artificial organs in the body. However, after the reopening of lockdown measures, the demand for artificial organs is expected to increase in the coming years.

Artificial Organs Market Trends:

At present, the increasing demand for artificial organs due to the decreasing number of organ donors around the world represents one of the major factors influencing the market positively. Additionally, the rising adoption of artificial organs due to the increasing number of organ failures and disabilities among individuals across the globe is contributing to the growth of the market. Apart from this, various technological advancements in medical devices, such as wearable technology, microchips technology, and non-invasive diagnostic techniques, are offering a positive market outlook. In addition to this, the increasing utilization of advanced biomaterials in artificial organs to provide high strength, conductivity, and bio-compatibility is offering lucrative growth opportunities to industry investors. Moreover, there is a rise in demand for artificial organs that are highly suitable to enhance the lives of individuals around the world. This, coupled with the growing number of lifestyle-related diseases among the masses due to the changing habits and lifestyles, is bolstering the growth of the market. In line with this, the rising preference for monitoring artificial organs by using precise diagnostics is impelling the growth of the market. Furthermore, key players are introducing artificial intelligence (AI) and embedded sensors in artificial organs, which is strengthening the growth of the market.

Key Market Segmentation:

Type Insights:

  • Artificial Kidney
  • Artificial Heart
  • Artificial Pancreas
  • Cochlear Implants
  • Others

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for artificial organs. Some of the factors driving the North America artificial organs market included the growing prevalence of organ failures and disabilities among the masses, rising adoption for the treatment of several cancers, and increasing number of diseases and low availability of organ donors. In addition to this, key players operating in the region are introducing miniature heart pump devices that provide smart patient management for enhanced patient experience, which is contributing to the growth of the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global artificial organs market. Some of the companies covered in the report include:

  • Abiomed, Inc.
  • HeartWare International, Inc.
  • Edwards Lifesciences Corp
  • Boston Scientific Corporation
  • Cochlear Limited
  • Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.What are artificial organs?
  • 2.How big is the artificial organs market?
  • 3.What is the expected growth rate of the global artificial organs market during 2025-2033?
  • 4.What are the key factors driving the global artificial organs market?
  • 5.What is the leading segment of the global artificial organs market based on the type?
  • 6.What are the key regions in the global artificial organs market?
  • 7.Who are the key players/companies in the global artificial organs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Organs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Region
  • 5.6 Market Forecast
  • 5.7 SWOT Analysis
    • 5.7.1 Overview
    • 5.7.2 Strengths
    • 5.7.3 Weaknesses
    • 5.7.4 Opportunities
    • 5.7.5 Threats
  • 5.8 Value Chain Analysis
    • 5.8.1 Overview
    • 5.8.2 Research and Development
    • 5.8.3 Raw Material Procurement
    • 5.8.4 Manufacturing
    • 5.8.5 Marketing
    • 5.8.6 Distribution
    • 5.8.7 End-Use
  • 5.9 Porters Five Forces Analysis
    • 5.9.1 Overview
    • 5.9.2 Bargaining Power of Buyers
    • 5.9.3 Bargaining Power of Suppliers
    • 5.9.4 Degree of Competition
    • 5.9.5 Threat of New Entrants
    • 5.9.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Artificial Kidney
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Artificial Heart
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Artificial Pancreas
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cochlear Implants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Region

  • 7.1 North America
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Europe
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Asia Pacific
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Middle East and Africa
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Latin America
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Competitive Landscape

  • 8.1 Market Structure
  • 8.2 Key Players
  • 8.3 Profiles of Key Players
    • 8.3.1 Abiomed, Inc.
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Description
      • 8.3.1.3 Product Portfolio
      • 8.3.1.4 Financials
      • 8.3.1.5 SWOT Analysis
    • 8.3.2 HeartWare International, Inc.
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Description
      • 8.3.2.3 Product Portfolio
      • 8.3.2.4 Financials
      • 8.3.2.5 SWOT Analysis
    • 8.3.3 Edwards Lifesciences Corp
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Description
      • 8.3.3.3 Product Portfolio
      • 8.3.3.4 Financials
      • 8.3.3.5 SWOT Analysis
    • 8.3.4 Boston Scientific Corporation
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Description
      • 8.3.4.3 Product Portfolio
      • 8.3.4.4 Financials
      • 8.3.4.5 SWOT Analysis
    • 8.3.5 Cochlear Limited
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Description
      • 8.3.5.3 Product Portfolio
      • 8.3.5.4 Financials
      • 8.3.5.5 SWOT Analysis

List of Figures

  • Figure 1: Global: Artificial Organs Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Organs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Artificial Organs Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Artificial Organs Market: Breakup by Region (in %), 2024
  • Figure 5: Global: Artificial Organs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 6: Global: Artificial Organs Industry: SWOT Analysis
  • Figure 7: Global: Artificial Organs Industry: Value Chain Analysis
  • Figure 8: Global: Artificial Organs Industry: Porter's Five Forces Analysis
  • Figure 9: Global: Artificial Organs (Artificial Kidney) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Artificial Organs (Artificial Kidney) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Artificial Organs (Artificial Heart) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Artificial Organs (Artificial Heart) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Artificial Organs (Artificial Pancreas) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Artificial Organs (Artificial Pancreas) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Artificial Organs (Cochlear Implants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Artificial Organs (Cochlear Implants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Artificial Organs (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Artificial Organs (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: North America: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: North America: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Europe: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Europe: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Asia Pacific: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Asia Pacific: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Middle East and Africa: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Middle East and Africa: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Latin America: Artificial Organs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Latin America: Artificial Organs Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Artificial Organs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Organs Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Organs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 4: Global: Artificial Organs Market Structure
  • Table 5: Global: Artificial Organs Market: Key Players